Traitement du cancer
- 专利权人:
- Novartis Pharma GmbH;Novartis AG
- 发明人:
- 申请号：
- EP14164561.4
- 公开号：
- EP2764865A2
- 申请日:
- 2002.02.18
- 申请国别(地区):
- EP
- 年份:
- 2014
- 代理人:
- 摘要：
- The disclosure provides 40-O-(2-hydroxyethyl)-rapamycin in combination with vinorelbine for use in the prevention, delay of progression or treatment of breast cancer.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Association d'un dérivé de rapamycine et de létrozole pour le traitement du cancer du sein
- APPLICATION OF DERIVATIVE RAMAPICIN
- MTOR inhibitors in the treatment of endocrine tumors
- Combination of a derivative of rapamycin and letrozole to treat breast cancer
- Application of 40-O-(2-hydroxyethyl)-rapamycin for treatment of solid kidney tumors
